BMO Capital Downgrades Eli Lilly (LLY) to Underperform; 'Unfavorable Risk/Reward'
Tweet Send to a Friend
BMO Capital downgraded Eli Lilly (NYSE: LLY) from Market Perform to Underperform with a price target of $71.00 (from $73.00).Analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
